BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34631540)

  • 1. Comparative Study of Pulmonary Combined Large-Cell Neuroendocrine Carcinoma and Combined Small-Cell Carcinoma in Surgically Resected High-Grade Neuroendocrine Tumors of the Lung.
    Wang Y; Qian F; Chen Y; Yang Z; Hu M; Lu J; Zhang Y; Zhang W; Cheng L; Han B
    Front Oncol; 2021; 11():714549. PubMed ID: 34631540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma.
    Wang Y; Chen Y; Yang Z; Qian F; Hu M; Lu J; Zhang Y; Zhang W; Wang K; Han B
    Ann Surg Oncol; 2022 Sep; 29(9):5666-5678. PubMed ID: 35543906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
    Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
    BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of large cell neuroendocrine carcinoma and small cell lung carcinoma in high-grade neuroendocrine tumors of the lung: a large population-based study.
    Wang J; Ye L; Cai H; Jin M
    J Cancer; 2019; 10(18):4226-4236. PubMed ID: 31413741
    [No Abstract]   [Full Text] [Related]  

  • 5. Different clinical characteristics and survival between surgically resected pure and combined small cell lung cancer.
    Li Y; Wang Y; Zhou W; Chen Y; Lou Y; Qian F; Lu J; Jiang H; Xiang B; Zhang Y; Han B; Zhang W
    Thorac Cancer; 2022 Oct; 13(19):2711-2722. PubMed ID: 36054506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
    Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
    Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between Advanced Large Cell Neuroendocrine Carcinoma and Advanced Small Cell Lung Cancer: A Propensity Score Matching Analysis.
    Yang W; Wang W; Li Z; Wu J; Xu X; Chen C; Ye X
    J Cancer; 2023; 14(9):1541-1552. PubMed ID: 37325062
    [No Abstract]   [Full Text] [Related]  

  • 8. Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells?
    Zhou F; Hou L; Ding T; Song Q; Chen X; Su C; Li W; Gao G; Ren S; Wu F; Fan J; Wu C; Zhang J; Zhou C
    Lung Cancer; 2018 Feb; 116():30-37. PubMed ID: 29413048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
    Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined large cell neuroendocrine carcinoma: clinical characteristics, prognosis and postoperative management.
    Yang Z; Wang Y; Chen Y; Qian F; Zhang Y; Hu M; Zhang W; Han B
    Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35147672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Features and Outcomes Analysis of Surgical Resected Pulmonary Large-Cell Neuroendocrine Carcinoma With Adjuvant Chemotherapy.
    Shen Y; Hu F; Li C; Xu J; Zhong R; Zhang X; Chu T; Han B
    Front Oncol; 2020; 10():556194. PubMed ID: 33335851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and prognostic factors of surgically resected combined small cell lung cancer: a retrospective study.
    Lei Y; Feng H; Qiang H; Shang Z; Chang Q; Qian J; Zhang Y; Zhong R; Fan X; Chu T
    Lung Cancer; 2020 Aug; 146():244-251. PubMed ID: 32592985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High grade neuroendocrine lung tumors: pathological characteristics, surgical management and prognostic implications.
    Grand B; Cazes A; Mordant P; Foucault C; Dujon A; Guillevin EF; Barthes FLP; Riquet M
    Lung Cancer; 2013 Sep; 81(3):404-409. PubMed ID: 23769675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of perioperative chemotherapy for pulmonary high-grade neuroendocrine carcinomas: a propensity score matching analysis.
    Ogawa H; Tanaka Y; Kitamura Y; Shimizu N; Doi T; Hokka D; Tane S; Nishio W; Yoshimura M; Maniwa Y
    J Thorac Dis; 2019 Apr; 11(4):1145-1154. PubMed ID: 31179056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas.
    Wang H; Yan L; Zhu Y; Sun W; Yang X; Liu X; Chi K; Huang X; Zhou L; Lin D
    Hum Pathol; 2023 Dec; 142():81-89. PubMed ID: 37742943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer.
    Li F; Yang Y; Xu Y; Li K; Song L; Xue Y; Dong D
    Medicine (Baltimore); 2023 Jan; 102(4):e32781. PubMed ID: 36705391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and treatment outcomes of resected large cell neuroendocrine carcinoma of the lung.
    Moon JY; Choi SH; Kim TH; Lee J; Pyo JH; Kim YT; Lee SJ; Yoon HI; Cho J; Lee CG
    Radiat Oncol J; 2021 Dec; 39(4):288-296. PubMed ID: 34986550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic strategies and genetic profile comparisons in small cell carcinoma and large cell neuroendocrine carcinoma of the lung using next-generation sequencing.
    Ito M; Miyata Y; Hirano S; Kimura S; Irisuna F; Ikeda K; Kushitani K; Tsutani Y; Ueda D; Tsubokawa N; Takeshima Y; Okada M
    Oncotarget; 2017 Dec; 8(65):108936-108945. PubMed ID: 29312580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on large cell neuroendocrine carcinoma.
    Hiroshima K; Mino-Kenudson M
    Transl Lung Cancer Res; 2017 Oct; 6(5):530-539. PubMed ID: 29114469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I-IV Stage.
    Lowczak A; Kolasinska-Cwikla A; Osowiecka K; Glinka L; Palucki J; Rzepko R; Doboszynska A; Cwikla JB
    Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33525370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.